Current Edition

Volume 15 Issue 2

The Future of AI in Biotechnology

On the Precipice of the New Technological Revolution The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms lik...
Continue Reading →
Volume 15 Issue 2

Cutting-edge Formulation is Needed to Enable the Next Generation of Oral Biologics

An Introduction to Oral Solid Dose Traditionally, the pharmaceutical market has been dominated by oral drug delivery – whether oral solid dose (OSD) or liquid suspen...
Continue Reading →
Volume 15 Issue 2

Individual Device Identification: Coding and Marking for the New Dimension in Patient Health and Safety

Counterfeit products and product piracy are serious issues for the pharmaceutical industry – but recent product marking requirements in developed economies, includin...
Continue Reading →
Volume 15 Issue 2

Potent Product Manufacturing in a Multi-product Facility

Highly potent drugs are becoming increasingly common in the drug development pipeline. The focus on oncology, rare diseases, and targeted therapies is grow...
Continue Reading →
Volume 15 Issue 2

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 to $43...
Continue Reading →
Volume 15 Issue 2

Choosing and Developing User-friendly Osmotic Laxatives for a More Patient-centric Portfolio

At least 1 in 10 people worldwide suffer from constipation at some point in their lives.1,2 It affects people of all ages and has many causes. The symptoms of consti...
Continue Reading →
Volume 15 Issue 2

Artificial Intelligence is a Core Pillar in the Evolution of Digital Health and Patient-centric Solutions

The US Food & Drug Administration has stated that digital technology is driving a revolution in healthcare. The lines between healthcare delivery and clinical re...
Continue Reading →
Volume 15 Issue 2

Net Zero Healthcare – Priorities for Decarbonising the Pharma Supply Chain

The climate and our health are inextricably linked. The effects of climate change on global health systems and outcomes are already clear, with WHO proclaiming it to...
Continue Reading →
Volume 15 Issue 2

Harnessing the Power of cMaaS in Pharma Logistics

Ensuring Regulatory Compliance and Sustainable Supply Chain Management End-to-end digital visibility across the supply chain can be used to identify hotspots, sup...
Continue Reading →
Volume 15 Issue 2

Why an Outcome-driven Approach to Supply Chain is a Strategic Advantage for Pharmaceutical Businesses

Since 2020, the pharmaceutical industry has been grappling with frequent and rapid changes, shifting customer demands and increasing costs. In response, organisation...
Continue Reading →